|
GENEPHARM is managed by
experienced biotechnology entrepreneurs and world renowned
scientists in scientific advisory boards. With strong
research and development to production and
commercialization, GENEPHARM has set itself apart among
leading pharmaceutical companies.
|
|
 |
Dr. Lee is a general partner and
co-founder of AmKey Ventures, LLC, a venture
management company specializing in investments
in the biotech and pharmaceutical fields. Dr.
Lee is a co-founder of Pharmout Labs, Pharmdel
Inc, and BioKey Inc.. Dr. Lee has extensive
experience in the pharmaceutical industry at a
major pharmaceutical company, Syntex, for 13
years as well as early stage biomedical
companies at Sonus and Shaman Pharmaceuticals
for 7 years. Dr. Lee is an internationally known
pioneer in the field of steroid hormones
research. Dr. Lee has in depth experience in
analytical methods development and validation
for New Drug Application (NDA) as well as
various applications to the Food & Drug
Administration. Dr. Lee earned his Ph.D. degree
in Chemistry from the State University of New
York at Buffalo and his B.S. degree in
Biochemistry from National Taiwan University,
Taiwan. |
|
George J. Lee, Ph.D. |
|
Chairman of Board |
|
|
 |
Dr.
Huang has more than 20 years of medical and
pharmaceutical experience. After practicing as a
Surgeon in China for 7 years, Dr. Huang started
his pharmacology career at Stanford University
School of Medicine in 1990 working on
immunosuppresive agents for organ
transplantation. In 1995, he joined a
bio-pharmaceutical company, FibroGen, as
Scientist on Pharmacology, and advanced his
career to Manager, Director for Preclinical
Research. In 1999, he joined Connetics Corp, a
specialty pharmaceutical company focusing on
topical products for dermatology, and served as
Sr. Director for Preclinical Research and
Development. He has participated 5
dermatological product NDA filings and 11 IND
filings. |
|
Xinfan Huang, M.D. |
|
President and Chief Executive Officer
|
|
|
 |
Dr. Tanojo has more than 15 years of
pharmaceutical and product development
experience, specialized in formulation
development, skin biology and regulatory
submission for both chemical and biologics.
Before joining GENEPHARM, he was a formulation
Scientist at FibroGen and also served as a Sr.
Scientist, Preclinical Research and Development
at Connetics Corp, Palo Alto. He has developed
several technologies and products for
Dermatology. Dr. Tanojo received his PhD in
Pharmaceutical Sciences from Leiden University,
Leiden, The Netherlands, and was a Postdoctoral
Fellow at Department of Dermatology, University
of California at San Francisco. |
|
Hanafi Tanojo, Ph.D. |
|
Vice
President, Research and Development |
|
|
Team
Management Team
Company 